Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

NCT00987272 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
DRUG: Olopatadine Hydrochloride Ophthalmic Solution, 0.1%
DRUG: Olopatadine 0.2% Vehicle
DRUG: Olopatadine 0.1% Vehicle

Sponsor

Alcon Research